FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367296150> ?p ?o ?g. }

• W4367296150 abstract "<h3>Objective:</h3> To develop the ability to forecast seizures in patients with epilepsy without intracranial devices. <h3>Background:</h3> Seizure forecasting has been established using intracranial EEG, but minimally invasive devices may permit seizure forecasting and provide accurate seizure records. <h3>Design/Methods:</h3> Patients were recruited for ultra-long monitoring with a wearable device (Empatica E4, Fitbit Charge HR, or Fitbit Inspire) and concurrent ambulatory EEG monitoring (UNEEG SubQ, EpiMinder, NeuroPace RNS) at three sites. Wearable and EEG data from enrolled patients was recorded for 8 months or more. Self-reported electronic seizure diaries and periodic mood and symptom surveys were recorded by participants as well. Recorded data were analyzed to assess the ability to detect seizures, to identify circadian and multi-day cycles, and to forecast and detect seizures <h3>Results:</h3> Thirty-nine patients with epilepsy and one volunteer have recorded over 16000 days (43.8 years) of ambulatory wearable and EEG data, including over 1700 seizures. Nine patients left the study before completion due to device malfunctions, complications, poor adherence, or unanticipated seizure freedom. Analysis in this cohort has established the following: Seizure forecasting significantly better than chance in 6 patients with EEG confirmation of seizures using the wrist-worn Empatica E4 device for 6–12 months. Results from a large-scale data science contest on eval.ai will be presented. Seizure forecasting using the subscalp EEG significantly greater than chance in 5 of 6 patients with at least four seizures recorded over at least three months using a Bidirectional LSTM neural network. Heart rate circadian and multi-day cycles were significantly phase-locked with self-reported seizure likelihood in 10 of 19 patients Tonic and phasic electrodermal activity, heart rate, and actigraphy cycles are significantly correlated with iEEG-confirmed seizures in 11 patients measured over at least 8 months. <h3>Conclusions:</h3> This project has established the feasibility of forecasting seizures using long-term cycles, wearable devices, and subcutaneous EEG. <b>Disclosure:</b> Dr. Brinkmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka Pharmaceuticals. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Brinkmann has a non-compensated relationship as a Co-Investigator with Medtronic Inc. that is relevant to AAN interests or activities. Dr. Nurse has received stock or an ownership interest from Seer Medical. The institution of Dr. Nurse has received research support from MTPConnect. The institution of Dr. Viana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG Medical. Mona Nasseri has nothing to disclose. Dr. Kuhlmann has nothing to disclose. Dr. Karoly has received personal compensation for serving as an employee of Seer Medical. Dr. Karoly has received stock or an ownership interest from Seer Medical. An immediate family member of Dr. Karoly has received stock or an ownership interest from Seer Medical. The institution of Dr. Karoly has received research support from Australian Government National Health & Medical Research Council. Dr. Karoly has received intellectual property interests from a discovery or technology relating to health care. Tal Pal Attia has nothing to disclose. Nicholas M. Gregg, MD has nothing to disclose. Boney Joseph has nothing to disclose. Mr. Dümpelnann has nothing to disclose. Dr. Cook has received personal compensation for serving as an employee of Seer Medical Pty Ltd. Dr. Cook has received personal compensation for serving as an employee of EpiMinder Pty Ltd. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cook has stock in EpiMinder Pty Ltd . Dr. Cook has stock in Seer Medical Pty Ltd . The institution of Dr. Cook has received research support from NHMRC. Dr. Cook has received intellectual property interests from a discovery or technology relating to health care. Dr. Cook has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Andreas Schulze-Bonhage has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL, GW. Andreas Schulze-Bonhage has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BIAL, GW, EISAI, UCB. The institution of Dr. Richardson has received research support from Medical Research Council UK. The institution of Dr. Richardson has received research support from Epilepsy Research UK. The institution of Dr. Richardson has received research support from GW Pharma. The institution of Dr. Richardson has received research support from European Commission. The institution of Dr. Richardson has received research support from Autifony Therapeutics . The institution of Dr. Richardson has received research support from Epilepsy Foundation of America . Dr. Richardson has received intellectual property interests from a discovery or technology relating to health care. Dean Freestone has nothing to disclose." @default.
• W4367296150 created "2023-04-29" @default.
• W4367296150 creator A5017999042 @default.
• W4367296150 creator A5036093248 @default.
• W4367296150 creator A5036665919 @default.
• W4367296150 creator A5052643152 @default.
• W4367296150 creator A5054920655 @default.
• W4367296150 creator A5057958917 @default.
• W4367296150 creator A5066512588 @default.
• W4367296150 creator A5068014315 @default.
• W4367296150 creator A5069146692 @default.
• W4367296150 creator A5069212263 @default.
• W4367296150 creator A5070511138 @default.
• W4367296150 creator A5070704717 @default.
• W4367296150 creator A5079880645 @default.
• W4367296150 creator A5080726390 @default.
• W4367296150 creator A5083765806 @default.
• W4367296150 date "2023-04-25" @default.
• W4367296150 modified "2023-10-14" @default.
• W4367296150 title "Seizure Forecasting and Detection with Wearable Devices and Subcutaneous EEG – Outcomes from the My Seizure Gauge Trial (PL4.001)" @default.
• W4367296150 doi "https://doi.org/10.1212/wnl.0000000000203901" @default.
• W4367296150 hasPublicationYear "2023" @default.
• W4367296150 type Work @default.
• W4367296150 citedByCount "0" @default.
• W4367296150 crossrefType "proceedings-article" @default.
• W4367296150 hasAuthorship W4367296150A5017999042 @default.
• W4367296150 hasAuthorship W4367296150A5036093248 @default.
• W4367296150 hasAuthorship W4367296150A5036665919 @default.
• W4367296150 hasAuthorship W4367296150A5052643152 @default.
• W4367296150 hasAuthorship W4367296150A5054920655 @default.
• W4367296150 hasAuthorship W4367296150A5057958917 @default.
• W4367296150 hasAuthorship W4367296150A5066512588 @default.
• W4367296150 hasAuthorship W4367296150A5068014315 @default.
• W4367296150 hasAuthorship W4367296150A5069146692 @default.
• W4367296150 hasAuthorship W4367296150A5069212263 @default.
• W4367296150 hasAuthorship W4367296150A5070511138 @default.
• W4367296150 hasAuthorship W4367296150A5070704717 @default.
• W4367296150 hasAuthorship W4367296150A5079880645 @default.
• W4367296150 hasAuthorship W4367296150A5080726390 @default.
• W4367296150 hasAuthorship W4367296150A5083765806 @default.
• W4367296150 hasConcept C118552586 @default.
• W4367296150 hasConcept C126322002 @default.
• W4367296150 hasConcept C149635348 @default.
• W4367296150 hasConcept C150594956 @default.
• W4367296150 hasConcept C2778186239 @default.
• W4367296150 hasConcept C35785553 @default.
• W4367296150 hasConcept C41008148 @default.
• W4367296150 hasConcept C42219234 @default.
• W4367296150 hasConcept C522805319 @default.
• W4367296150 hasConcept C548259974 @default.
• W4367296150 hasConcept C71924100 @default.
• W4367296150 hasConcept C99508421 @default.
• W4367296150 hasConceptScore W4367296150C118552586 @default.
• W4367296150 hasConceptScore W4367296150C126322002 @default.
• W4367296150 hasConceptScore W4367296150C149635348 @default.
• W4367296150 hasConceptScore W4367296150C150594956 @default.
• W4367296150 hasConceptScore W4367296150C2778186239 @default.
• W4367296150 hasConceptScore W4367296150C35785553 @default.
• W4367296150 hasConceptScore W4367296150C41008148 @default.
• W4367296150 hasConceptScore W4367296150C42219234 @default.
• W4367296150 hasConceptScore W4367296150C522805319 @default.
• W4367296150 hasConceptScore W4367296150C548259974 @default.
• W4367296150 hasConceptScore W4367296150C71924100 @default.
• W4367296150 hasConceptScore W4367296150C99508421 @default.
• W4367296150 hasLocation W43672961501 @default.
• W4367296150 hasOpenAccess W4367296150 @default.
• W4367296150 hasPrimaryLocation W43672961501 @default.
• W4367296150 hasRelatedWork W1982563968 @default.
• W4367296150 hasRelatedWork W2043498347 @default.
• W4367296150 hasRelatedWork W2066661146 @default.
• W4367296150 hasRelatedWork W2296148144 @default.
• W4367296150 hasRelatedWork W2312635070 @default.
• W4367296150 hasRelatedWork W2359365468 @default.
• W4367296150 hasRelatedWork W2538728129 @default.
• W4367296150 hasRelatedWork W2766832809 @default.
• W4367296150 hasRelatedWork W2904782695 @default.
• W4367296150 hasRelatedWork W2969016624 @default.
• W4367296150 isParatext "false" @default.
• W4367296150 isRetracted "false" @default.
• W4367296150 workType "article" @default.